1267.5000 -1.50 (-0.12%)
NSE Jun 18, 2026 15:31 PM
Volume: 774.1K
 

1267.50
-0.12%
Deven Choksey
Dr. Reddy’s Laboratories Ltd. has entered into a definitive agreement with Janssen Pharmaceutica NV, an affiliate of Johnson & Johnson, to acquire the STUGERON® brand along with its leading local brands STUGERON® FORTE and STUGERON® PLUS.
Dr. Reddy's Laborato.. has an average target of 1359.44 from 9 brokers.
More from Dr. Reddy's Laboratories Ltd.
Recommended